Response by Pasupathy et al to Letters Regarding Article, "Early Use of N-acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Infarct Size (The NACIAM Trial [ N-Acetylcysteine in Acute Myocardial Infarction])"

Circulation. 2018 Mar 27;137(13):1424-1425. doi: 10.1161/CIRCULATIONAHA.117.032512.

Sivabaskari Pasupathy^{1

2

3}, Rosanna Tavella^{1

2

3}, John F Beltrame^{1

2

3

4}

¹ Department of Medicine, University of Adelaide, SA, Australia (S.P., R.T., J.F.B.).
² Basil Hetzel Institute for Translational Health Research, Woodville, SA, Australia (S.P., R.T., J.F.B.).
³ Central Adelaide Local Health Network, SA, Australia (S.P., R.T., J.F.B.).
⁴ Northern Adelaide Local Health Network, SA, Australia (J.F.B.).

No abstract available

Publication types